<SEC-DOCUMENT>0001193125-22-173902.txt : 20220614
<SEC-HEADER>0001193125-22-173902.hdr.sgml : 20220614
<ACCEPTANCE-DATETIME>20220614165806
ACCESSION NUMBER:		0001193125-22-173902
CONFORMED SUBMISSION TYPE:	8-K
PUBLIC DOCUMENT COUNT:		13
CONFORMED PERIOD OF REPORT:	20220608
ITEM INFORMATION:		Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
ITEM INFORMATION:		Submission of Matters to a Vote of Security Holders
ITEM INFORMATION:		Financial Statements and Exhibits
FILED AS OF DATE:		20220614
DATE AS OF CHANGE:		20220614

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			MiNK Therapeutics, Inc.
		CENTRAL INDEX KEY:			0001840229
		STANDARD INDUSTRIAL CLASSIFICATION:	BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
		IRS NUMBER:				000000000
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		8-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-40908
		FILM NUMBER:		221015549

	BUSINESS ADDRESS:	
		STREET 1:		149 FIFTH AVENUE
		STREET 2:		SUITE 500
		CITY:			NEW YORK
		STATE:			NY
		ZIP:			10010
		BUSINESS PHONE:		212-994-8250

	MAIL ADDRESS:	
		STREET 1:		149 FIFTH AVENUE
		STREET 2:		SUITE 500
		CITY:			NEW YORK
		STATE:			NY
		ZIP:			10010

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	AgenTus Therapeutics, Inc.
		DATE OF NAME CHANGE:	20210112
</SEC-HEADER>
<DOCUMENT>
<TYPE>8-K
<SEQUENCE>1
<FILENAME>d364118d8k.htm
<DESCRIPTION>8-K
<TEXT>
<XBRL>
<?xml version="1.0" encoding="utf-8" ?>
<html xmlns:dei="http://xbrl.sec.gov/dei/2021" xmlns:us-types="http://fasb.org/us-types/2021-01-31" xmlns:nonnum="http://www.xbrl.org/dtr/type/non-numeric" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:inkt="http://minktherapeutics.com/20220608" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:utr="http://www.xbrl.org/2009/utr" xmlns:iso4217="http://www.xbrl.org/2003/iso4217" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2015-02-26" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns="http://www.w3.org/1999/xhtml">
<head>
<title>8-K</title>
<meta http-equiv="Content-Type" content="text/html" />
</head>
   <body><div style="display:none"> <ix:header> <ix:hidden> <ix:nonNumeric id="Hidden_dei_SecurityExchangeName" name="dei:SecurityExchangeName" contextRef="duration_2022-06-08_to_2022-06-08">NASDAQ</ix:nonNumeric> <ix:nonNumeric name="dei:AmendmentFlag" contextRef="duration_2022-06-08_to_2022-06-08">false</ix:nonNumeric> <ix:nonNumeric id="Hidden_dei_EntityCentralIndexKey" name="dei:EntityCentralIndexKey" contextRef="duration_2022-06-08_to_2022-06-08">0001840229</ix:nonNumeric> </ix:hidden> <ix:references> <link:schemaRef xlink:type="simple" xlink:href="inkt-20220608.xsd" xlink:arcrole="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase"></link:schemaRef> </ix:references> <ix:resources> <xbrli:context id="duration_2022-06-08_to_2022-06-08"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001840229</xbrli:identifier> </xbrli:entity> <xbrli:period> <xbrli:startDate>2022-06-08</xbrli:startDate> <xbrli:endDate>2022-06-08</xbrli:endDate> </xbrli:period> </xbrli:context> </ix:resources> </ix:header> </div> <div style="text-align:center"> <div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto"> <p style="line-height:1.0pt;margin-top:0pt;margin-bottom:0pt;border-bottom:1px solid #000000">&#160;</p> <p style="line-height:3.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000">&#160;</p> <p style="margin-top:4pt; margin-bottom:0pt; font-size:18pt; font-family:Times New Roman;font-weight:bold;text-align:center">UNITED STATES</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:18pt; font-family:Times New Roman;font-weight:bold;text-align:center">SECURITIES AND EXCHANGE COMMISSION</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman;font-weight:bold;text-align:center">Washington, D.C. 20549</p> <p style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</p> <div style="text-align:center"> <p style="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%;text-align:center;margin-left: auto;margin-right: auto">&#160;</p></div> <p style="margin-top:12pt; margin-bottom:0pt; font-size:18pt; font-family:Times New Roman;font-weight:bold;text-align:center">FORM <span style="white-space:nowrap"><ix:nonNumeric name="dei:DocumentType" contextRef="duration_2022-06-08_to_2022-06-08">8-K</ix:nonNumeric></span></p> <p style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</p> <div style="text-align:center"> <p style="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%;text-align:center;margin-left: auto;margin-right: auto">&#160;</p></div> <p style="margin-top:12pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman;font-weight:bold;text-align:center">CURRENT REPORT</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman;font-weight:bold;text-align:center">Pursuant to Section&#160;13 or 15(d)</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman;font-weight:bold;text-align:center">of the Securities Exchange Act of 1934</p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman;font-weight:bold;text-align:center">Date of Report (Date of earliest event reported): <ix:nonNumeric name="dei:DocumentPeriodEndDate" contextRef="duration_2022-06-08_to_2022-06-08" format="ixt:datemonthdayyearen">June&#160;8, 2022</ix:nonNumeric></p> <p style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</p> <div style="text-align:center"> <p style="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%;text-align:center;margin-left: auto;margin-right: auto">&#160;</p></div> <p style="margin-top:12pt; margin-bottom:0pt; font-size:24pt; font-family:Times New Roman;font-weight:bold;text-align:center"><ix:nonNumeric name="dei:EntityRegistrantName" contextRef="duration_2022-06-08_to_2022-06-08">MiNK Therapeutics, Inc.</ix:nonNumeric></p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:center">(Exact name of registrant as specified in its charter)</p> <p style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</p> <div style="text-align:center"> <p style="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%;text-align:center;margin-left: auto;margin-right: auto">&#160;</p></div> <p style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table cellspacing="0" cellpadding="0" style="border-collapse:collapse; font-family:Times New Roman; font-size:8pt;width:100%;border:0;margin:0 auto">
<tr>
<td style="width:34%"></td>
<td style="vertical-align:bottom"></td>
<td style="width:32%"></td>
<td style="vertical-align:bottom;width:1%"></td>
<td style="width:32%"></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style=" text-align: center;margin:auto; vertical-align:top"><span style="font-weight:bold"><ix:nonNumeric name="dei:EntityIncorporationStateCountryCode" contextRef="duration_2022-06-08_to_2022-06-08" format="ixt-sec:stateprovnameen">Delaware</ix:nonNumeric></span></td>
<td style="vertical-align:bottom">&#160;</td>
<td style=" text-align: center;margin:auto; vertical-align:top"><span style="font-weight:bold"><span style="white-space:nowrap"><ix:nonNumeric name="dei:EntityFileNumber" contextRef="duration_2022-06-08_to_2022-06-08">001-40908</ix:nonNumeric></span></span></td>
<td style="vertical-align:bottom">&#160;</td>
<td style=" text-align: center;margin:auto; vertical-align:top"><span style="font-weight:bold"><span style="white-space:nowrap"><ix:nonNumeric name="dei:EntityTaxIdentificationNumber" contextRef="duration_2022-06-08_to_2022-06-08">82-2142067</ix:nonNumeric></span></span></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<td style=" text-align: center;margin:auto; vertical-align:top"> <p style="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">(State or other jurisdiction</p> <p style="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">of incorporation)</p></td>
<td style="vertical-align:bottom">&#160;</td>
<td style=" text-align: center;margin:auto; vertical-align:top"> <p style="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">(Commission</p> <p style="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">File Number)</p></td>
<td style="vertical-align:bottom">&#160;</td>
<td style=" text-align: center;margin:auto; vertical-align:top"> <p style="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">(I.R.S. Employer</p> <p style="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">Identification No.)</p></td></tr></table> <p style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table cellspacing="0" cellpadding="0" style="border-collapse:collapse; font-family:Times New Roman; font-size:10pt;width:100%;border:0;margin:0 auto">
<tr>
<td style="width:100%"></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<td style=" text-align: center;margin:auto; vertical-align:top"> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:center"><ix:nonNumeric name="dei:EntityAddressAddressLine1" contextRef="duration_2022-06-08_to_2022-06-08">149 Fifth Avenue</ix:nonNumeric>, <ix:nonNumeric name="dei:EntityAddressAddressLine2" contextRef="duration_2022-06-08_to_2022-06-08">Suite 500</ix:nonNumeric></p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:center"><ix:nonNumeric name="dei:EntityAddressCityOrTown" contextRef="duration_2022-06-08_to_2022-06-08">New York</ix:nonNumeric>, <ix:nonNumeric name="dei:EntityAddressStateOrProvince" contextRef="duration_2022-06-08_to_2022-06-08">NY</ix:nonNumeric> <ix:nonNumeric name="dei:EntityAddressPostalZipCode" contextRef="duration_2022-06-08_to_2022-06-08">10010</ix:nonNumeric></p> <p style="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">(Address of principal executive offices, including zip code)</p></td></tr></table> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:center"><ix:nonNumeric name="dei:CityAreaCode" contextRef="duration_2022-06-08_to_2022-06-08">(212)</ix:nonNumeric> <span style="white-space:nowrap"><ix:nonNumeric name="dei:LocalPhoneNumber" contextRef="duration_2022-06-08_to_2022-06-08">994-8250</ix:nonNumeric></span></p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">(Registrant&#8217;s telephone number, including area code)</p> <p style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</p> <div style="text-align:center"> <p style="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%;text-align:center;margin-left: auto;margin-right: auto">&#160;</p></div> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Check the appropriate box below if the Form <span style="white-space:nowrap">8-K</span> filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:</p> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="border-collapse:collapse; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:4%;vertical-align:top"><ix:nonNumeric name="dei:WrittenCommunications" contextRef="duration_2022-06-08_to_2022-06-08" format="ixt-sec:boolballotbox">&#9744;</ix:nonNumeric></td>
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left">Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)</p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="border-collapse:collapse; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:4%;vertical-align:top"><ix:nonNumeric name="dei:SolicitingMaterial" contextRef="duration_2022-06-08_to_2022-06-08" format="ixt-sec:boolballotbox">&#9744;</ix:nonNumeric></td>
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left">Soliciting material pursuant to Rule <span style="white-space:nowrap">14a-12</span> under the Exchange Act (17 CFR <span style="white-space:nowrap">240.14a-12)</span></p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="border-collapse:collapse; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:4%;vertical-align:top"><ix:nonNumeric name="dei:PreCommencementTenderOffer" contextRef="duration_2022-06-08_to_2022-06-08" format="ixt-sec:boolballotbox">&#9744;</ix:nonNumeric></td>
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left"><span style="white-space:nowrap">Pre-commencement</span> communications pursuant to Rule <span style="white-space:nowrap">14d-2(b)</span> under the Exchange Act (17 CFR <span style="white-space:nowrap">240.14d-2(b))</span></p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="border-collapse:collapse; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:4%;vertical-align:top"><ix:nonNumeric name="dei:PreCommencementIssuerTenderOffer" contextRef="duration_2022-06-08_to_2022-06-08" format="ixt-sec:boolballotbox">&#9744;</ix:nonNumeric></td>
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left"><span style="white-space:nowrap">Pre-commencement</span> communications pursuant to Rule <span style="white-space:nowrap">13e-4(c)</span> under the Exchange Act (17 CFR <span style="white-space:nowrap">240.13e-4(c))</span></p></td></tr></table> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Securities registered pursuant to Section 12(b) of the Act:</p> <p style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table cellspacing="0" cellpadding="0" style="border-collapse:collapse; font-family:Times New Roman; font-size:8pt;width:100%;border:0;margin:0 auto">
<tr>
<td style="width:34%"></td>
<td style="vertical-align:bottom"></td>
<td style="width:32%"></td>
<td style="vertical-align:bottom;width:1%"></td>
<td style="width:32%"></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<td style=" text-align: center;margin:auto; border-bottom:1.00pt solid #000000;vertical-align:bottom;white-space:nowrap"> <p style="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">Title of each class</p></td>
<td style="vertical-align:bottom">&#160;</td>
<td style=" text-align: center;margin:auto; border-bottom:1.00pt solid #000000;vertical-align:bottom"> <p style="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">Trading</p> <p style="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">symbol(s)</p></td>
<td style="vertical-align:bottom">&#160;</td>
<td style=" text-align: center;margin:auto; border-bottom:1.00pt solid #000000;vertical-align:bottom"> <p style="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">Name of each exchange</p> <p style="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">on which registered</p></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style=" text-align: center;margin:auto; vertical-align:top"><span style="font-weight:bold"><ix:nonNumeric name="dei:Security12bTitle" contextRef="duration_2022-06-08_to_2022-06-08">Common stock, par value $0.00001</ix:nonNumeric></span></td>
<td style="vertical-align:bottom">&#160;</td>
<td style=" text-align: center;margin:auto; vertical-align:top"><span style="font-weight:bold"><ix:nonNumeric name="dei:TradingSymbol" contextRef="duration_2022-06-08_to_2022-06-08">INKT</ix:nonNumeric></span></td>
<td style="vertical-align:bottom">&#160;</td>
<td style=" text-align: center;margin:auto; vertical-align:top"><span style="font-weight:bold"> <span style=" -sec-ix-hidden:Hidden_dei_SecurityExchangeName">The Nasdaq Capital Market</span> </span></td></tr></table> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (&#167;230.405 of this chapter) or Rule <span style="white-space:nowrap">12b-2</span> of the Securities Exchange Act of 1934 <span style="white-space:nowrap">(&#167;240.12b-2</span> of this chapter).</p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Emerging growth company&#160;&#160;<ix:nonNumeric name="dei:EntityEmergingGrowthCompany" contextRef="duration_2022-06-08_to_2022-06-08" format="ixt-sec:boolballotbox">&#9746;</ix:nonNumeric></p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section&#160;13(a) of the Exchange Act.&#160;&#160;<ix:nonNumeric name="dei:EntityExTransitionPeriod" contextRef="duration_2022-06-08_to_2022-06-08" format="ixt-sec:boolballotbox">&#9744;</ix:nonNumeric></p> <p style="font-size:10pt;margin-top:0pt;margin-bottom:0pt">&#160;</p> <p style="line-height:1.0pt;margin-top:0pt;margin-bottom:0pt;border-bottom:1px solid #000000">&#160;</p> <p style="line-height:3.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000">&#160;</p></div></div>

<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%" />

<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">

<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:11%;vertical-align:top" align="left"><span style="font-weight:bold">Item&#160;5.02</span></td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:left">Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers. </p></td></tr></table> <p style="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">On June&#160;8, 2022, the Board of Directors of MiNK Therapeutics, Inc. (the &#8220;Company&#8221;) approved an Executive Change of Control Plan and form of Participation Agreement (the &#8220;Plan&#8221;). Each of the Company&#8217;s Executives (as defined in the Plan) is eligible to participate in the Plan. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Under the terms of the Plan, if a change of control (as defined in the Plan) occurs and the Executive is employed by the Company on the date of such change of control, then 50% of any stock options, restricted stock units or shares of restricted stock of the Company previously granted or issued to the Executive that are outstanding and unvested as of the date of the change of control and for which vesting is solely based on the passage of time shall become vested, exercisable and, in the case of shares of restricted stock, no longer subject to forfeiture. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Plan provides for certain payments and benefits upon termination following a change of control. Under the terms of the Plan, if a change of control occurs and the Company terminates the applicable Executive&#8217;s employment other than for Cause (as defined in the Plan) or the Executive terminates their employment for Good Reason (as defined in the Plan) within 18 months following a change of control, the Executive will be entitled to the following: </p> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:1%">&#160;</td>
<td style="width:2%;vertical-align:top" align="left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt;text-align:left">one lump sum payment equal to the sum of: (a)&#160;the Executive&#8217;s 12 months base salary in effect on the date of termination (or, if greater, as in effect prior to any reduction to such base salary following the change of control), plus an amount equal to the higher of (A)&#160;the Executive&#8217;s target incentive bonus for the year in which the Executive&#8217;s employment terminates (or, if greater, as in effect prior to any reduction to such target incentive bonus following the change of control), or (B)&#160;the actual incentive bonus paid to the Executive, if any, under the Company&#8217;s incentive plan for the last full fiscal year preceding the year in which the Executive&#8217;s employment terminates; </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:1%">&#160;</td>
<td style="width:2%;vertical-align:top" align="left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt;text-align:left">if the Executive timely elects COBRA continuation coverage, the Company shall also pay the employer portion of the group medical and dental premium payments as in effect on the date of the termination of employment for the Executive and his/her qualified dependents until the earlier of (i)&#160;the end of the <span style="white-space:nowrap">12-month</span> period following the date of termination of employment, or (ii)&#160;the date on which the Executive ceases to be eligible for COBRA continuation coverage for any reason or such coverage otherwise terminates; </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:1%">&#160;</td>
<td style="width:2%;vertical-align:top" align="left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt;text-align:left">(I) any outstanding unvested options granted or issued to the Executive as of the date of the change of control shall become vested and shall be exercisable for 90 days following termination of the Executive&#8217;s employment (but not following the original term of such options), (II) any shares of unvested restricted stock of the Company or unvested restricted stock units granted or issued to the Executive as of the date of the change of control shall become vested and no longer subject to forfeiture (in the case of restricted stock), in the case of (I)&#160;and (II), assuming that any performance vesting conditions associated with a grant of options, restricted stock or restricted stock units are satisfied, and (III)&#160;the Company will provide the Executive with an outplacement benefit in the form of a <span style="white-space:nowrap">lump-sum</span> payment of $10,000 plus an additional <span style="white-space:nowrap">lump-sum</span> payment in an amount sufficient, after giving effect to all federal, state and other taxes with respect to such additional payment, to make the Executive whole for all taxes (including withholding taxes) on such outplacement assistance benefit. </p></td></tr></table> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Plan includes a <span style="white-space:nowrap">non-compete</span> provision that precludes the Executive, during the <span style="white-space:nowrap">Non-Competition</span> Period (as defined in the Plan), from engaging in in any manner in any activity that is directly or indirectly competitive with the business of the Company or any of its Affiliates (as defined in the Plan) as conducted or under consideration at any time during the Executive&#8217;s employment. Restricted activity includes, without limitation, accepting employment or a consulting position with any Person (as defined in the Plan) who is, or at any time within 12 months prior to termination of the Executive&#8217;s employment has been, a competitor or a customer of the Company or any of its Affiliates. The Plan also includes a <span style="white-space:nowrap">non-solicitation</span> provision. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The foregoing description of the Plan does not purport to be complete and is qualified in its entirety by reference to the full text of the Plan, which is attached as Exhibit 10.1 and incorporated by reference into this Current Report on Form <span style="white-space:nowrap">8-K.</span> </p> <p style="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:11%;vertical-align:top" align="left"><span style="font-weight:bold">Item&#160;5.07</span></td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:left">Submission of Matters to a Vote of Security Holders. </p></td></tr></table> <p style="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Company held its Annual Meeting of Stockholders (the &#8220;Annual Meeting&#8221;) on June&#160;8, 2022. A total of 28,243,602 shares of common stock, representing 84.2% of the shares outstanding and eligible to vote and constituting a quorum, were present at the Annual Meeting or represented by valid proxies. At the Annual Meeting, the Company&#8217;s stockholders voted on </p>
</div></div>



<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%" />

<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">
 <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
the following matters, which are described in detail in the Company&#8217;s Definitive Proxy Statement filed with the U.S. Securities and Exchange Commission on April&#160;29, 2022: (i) to elect Peter Behner, Jennifer Buell and Ulf Wiinberg as Class&#160;I directors, each for a term of three years expiring at the 2025 Annual Meeting of Stockholders (&#8220;Proposal 1&#8221;) and (ii)&#160;to ratify the appointment of KPMG LLP as the Company&#8217;s independent registered public accounting firm for the fiscal year ending December&#160;31, 2022 (&#8220;Proposal 2&#8221;). </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Company&#8217;s stockholders elected each of the Class&#160;I director nominees nominated for election in Proposal 1 at the Annual Meeting. The Company&#8217;s stockholders voted for the Class&#160;I directors as follows: </p> <p style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table cellspacing="0" cellpadding="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;width:92%;border:0;margin:0 auto">


<tr>

<td style="width:18%"></td>

<td style="vertical-align:bottom"></td>
<td style="width:19%"></td>

<td style="vertical-align:bottom;width:1%"></td>
<td style="width:20%"></td>

<td style="vertical-align:bottom;width:1%"></td>
<td style="width:20%"></td>

<td style="vertical-align:bottom;width:1%"></td>
<td style="width:19%"></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<td style="border-bottom:1.00pt solid #000000;vertical-align:bottom;white-space:nowrap"> <p style="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman;font-weight:bold">Class&#160;I Director Nominees</p></td>
<td style="vertical-align:bottom">&#160;</td>
<td align="center" style="border-bottom:1.00pt solid #000000;vertical-align:bottom"> <p style="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">For</p></td>
<td style="vertical-align:bottom">&#160;</td>
<td align="center" style="border-bottom:1.00pt solid #000000;vertical-align:bottom"> <p style="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">Against</p></td>
<td style="vertical-align:bottom">&#160;</td>
<td align="center" style="border-bottom:1.00pt solid #000000;vertical-align:bottom"> <p style="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">Withheld</p></td>
<td style="vertical-align:bottom">&#160;</td>
<td align="center" style="border-bottom:1.00pt solid #000000;vertical-align:bottom"> <p style="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">Broker <span style="white-space:nowrap">Non-Votes</span></p></td></tr>


<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman;font-weight:bold">Peter&#160;Behner</p></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom;white-space:nowrap" align="center">27,207,649</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom;white-space:nowrap" align="center">0</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom;white-space:nowrap" align="center">467,723</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom;white-space:nowrap" align="center">568,230</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman;font-weight:bold">Jennifer&#160;Buell</p></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom;white-space:nowrap" align="center">27,194,848</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom;white-space:nowrap" align="center">0</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom;white-space:nowrap" align="center">480,524</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom;white-space:nowrap" align="center">568,230</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman;font-weight:bold">Ulf&#160;Wiinberg</p></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom;white-space:nowrap" align="center">27,171,244</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom;white-space:nowrap" align="center">0</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom;white-space:nowrap" align="center">504,128</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom;white-space:nowrap" align="center">568,230</td></tr>
</table> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Company&#8217;s stockholders approved Proposal 2. The votes cast at the Annual Meeting were as follows: </p> <p style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table cellspacing="0" cellpadding="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:8pt;width:92%;border:0;margin:0 auto">


<tr>

<td style="width:24%"></td>

<td style="vertical-align:bottom"></td>
<td style="width:24%"></td>

<td style="vertical-align:bottom;width:1%"></td>
<td style="width:25%"></td>

<td style="vertical-align:bottom;width:1%"></td>
<td style="width:24%"></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<td align="center" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;white-space:nowrap"> <p style="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">For</p></td>
<td style="vertical-align:bottom">&#160;</td>
<td align="center" style="border-bottom:1.00pt solid #000000;vertical-align:bottom"> <p style="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">Against</p></td>
<td style="vertical-align:bottom">&#160;</td>
<td align="center" style="border-bottom:1.00pt solid #000000;vertical-align:bottom"> <p style="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">Abstain</p></td>
<td style="vertical-align:bottom">&#160;</td>
<td align="center" style="border-bottom:1.00pt solid #000000;vertical-align:bottom"> <p style="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">Broker <span style="white-space:nowrap">Non-Votes</span></p></td></tr>


<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="vertical-align:top" align="center"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman;text-align:center">28,118,622</p></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom;white-space:nowrap" align="center">124,694</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom;white-space:nowrap" align="center">286</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom;white-space:nowrap" align="center">N/A</td></tr>
</table> <p style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:11%;vertical-align:top" align="left"><span style="font-weight:bold">Item&#160;9.01</span></td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:left">Financial Statements and Exhibits. </p></td></tr></table> <p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">(d) Exhibits </p> <p style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table cellspacing="0" cellpadding="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;width:100%;border:0;margin:0 auto">


<tr>

<td></td>

<td style="vertical-align:bottom;width:4%"></td>
<td style="width:93%"></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<td style="vertical-align:bottom;white-space:nowrap" align="center"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00pt solid #000000; display:inline-block; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">Exhibit<br />No.</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom;white-space:nowrap"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00pt solid #000000; display:table-cell; font-size:8pt; font-family:Times New Roman;font-weight:bold">Description</p></td></tr>


<tr style="font-size:1pt">
<td style="height:6pt"></td>
<td style="height:6pt" colspan="2"></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top;white-space:nowrap">10.1</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top"><a href="d364118dex101.htm">MiNK Therapeutics, Inc. Executive Change of Control Plan </a></td></tr>
<tr style="font-size:1pt">
<td style="height:6pt"></td>
<td style="height:6pt" colspan="2"></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top;white-space:nowrap">104</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top">Cover Page Interactive Data File (embedded within the Inline XBRL document)</td></tr>
</table>
</div></div>



<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%" />

<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">
 <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:center">SIGNATURES </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. </p> <p style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table cellspacing="0" cellpadding="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;width:100%;border:0">


<tr>

<td style="width:45%"></td>

<td style="vertical-align:bottom;width:1%"></td>
<td style="width:4%"></td>

<td style="vertical-align:bottom"></td>
<td style="width:3%"></td>

<td style="vertical-align:bottom;width:1%"></td>
<td style="width:45%"></td></tr>


<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:bottom">&#160;&#160;Date: June&#160;14, 2022</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom" colspan="3">MiNK Therapeutics, Inc.</td></tr>
<tr style="font-size:1pt">
<td style="height:12pt"></td>
<td style="height:12pt" colspan="2"></td>
<td style="height:12pt" colspan="2"></td>
<td style="height:12pt" colspan="2"></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">By:</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"> <p style="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">/s/ Jennifer S. Buell, Ph.D.</p></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">Jennifer S. Buell, Ph.D.</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">President and Chief Executive Officer</td></tr>
</table>
</div></div>

</body></html>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.1
<SEQUENCE>2
<FILENAME>d364118dex101.htm
<DESCRIPTION>EX-10.1
<TEXT>
<HTML><HEAD>
<TITLE>EX-10.1</TITLE>
</HEAD>
 <BODY BGCOLOR="WHITE">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right"><B>Exhibit 10.1 </B></P>
<P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>MINK THERAPEUTICS, INC. </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>EXECUTIVE CHANGE OF CONTROL PLAN </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">Subject to the terms and conditions hereinafter set forth, MiNK Therapeutics, Inc., a Delaware corporation, (the &#147;<B>Company</B>&#148;)
has established this Executive Change of Control Plan (the &#147;<B>Plan</B>&#148;) as of June&nbsp;8, 2022 (the &#147;<B>Effective Date</B>&#148;) to offer certain compensation and benefits to certain Executives (as defined herein) in the event of
a Change of Control (as defined herein) and/or certain terminations of employment following a Change of Control on or after the Effective Date, subject to the terms and conditions set forth in this Plan and the Participation Agreement to be executed
by each Executive wishing to participate in this Plan, a form of which is attached hereto as <U>Exhibit A</U> (the &#147;<B>Participation Agreement</B>&#148;). </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">1. <U>Definitions</U>. For purposes of the Plan, the following definitions apply: </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(a) &#147;<B>Affiliates</B>&#148; means all persons and entities directly or indirectly controlling, controlled by or under common control with
the Company, where control may be by either management authority or equity interest. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b) &#147;<B>Cause</B>&#148;, as determined by the
Company, means, as to any Executive: (i)&nbsp;a substantial failure of the Executive to perform the Executive&#146;s duties and responsibilities to the Company or any of its subsidiaries or substantial negligence in the performance of such duties
and responsibilities; (ii)&nbsp;the commission by the Executive of a felony or a crime involving moral turpitude; (iii)&nbsp;the commission by the Executive of theft, fraud, embezzlement, material breach of trust or any material act of dishonesty
involving the Company or any of its subsidiaries; (iv)&nbsp;a significant violation by the Executive of the Code of Business Conduct and Ethics of the Company or any of its subsidiaries of any material policy of the Company or any of its
subsidiaries, or of any statutory or common law duty of loyalty to the Company or any of its subsidiaries; (v)&nbsp;material breach of any of the terms of the Plan, or of the terms of any other agreement between the Company or any of its
subsidiaries and the Executive; or (vi)&nbsp;other conduct by the Executive that could be expected to be harmful to the business, interests or reputation of the Company </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(c) &#147;<B>Change of Control</B>&#148; shall mean: (i)&nbsp;the acquisition by any Organization of beneficial ownership (within the meaning
of Rule <FONT STYLE="white-space:nowrap">13d-3</FONT> promulgated under the Exchange Act) of 50% or more of the common stock of the Company; provided, however, that for purposes of this subsection (i), an acquisition shall not constitute a Change of
Control if it is: (A)&nbsp;by a Benefit Plan sponsored or maintained by the Company or an entity controlled by the Company or (B)&nbsp;by an entity pursuant to a transaction that complies with clauses (A), (B)&nbsp;and (C)&nbsp;of subsection
(iii)&nbsp;of this Section&nbsp;1(c); (ii)&nbsp;individuals who, as of the Effective Date, constitute the Board (the &#147;<B>Incumbent Board</B>&#148;) cease for any reason to constitute at least a majority of the Board; provided, however, that any
individual becoming a director subsequent to the Effective Date whose election, or nomination for election by the Company&#146;s stockholders, was approved by a vote of at least a majority of the directors then comprising the Incumbent Board (or a
majority of the members of a nominating committee who are members of the </P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
Incumbent Board) shall be treated as a member of the Incumbent Board unless he/she assumed office as a result of an actual or threatened election contest with respect to the election or removal
of directors or other actual or threatened solicitation of proxies or consents by or on behalf of an Organization other than the Board; (iii)&nbsp;consummation of a merger or consolidation involving the Company, or a sale or other disposition of all
or substantially all of the assets of the Company, (a &#147;transaction&#148;) in each case unless, immediately following such transaction, (A)&nbsp;the beneficial owners of the common stock of the Company outstanding immediately prior to such
transaction beneficially own, directly or indirectly, more than 50% of the combined voting power of the outstanding voting securities of the entity resulting from such transaction (including, without limitation, an entity which as a result of such
transaction owns the Company or all or substantially all of the Company&#146;s assets either directly or through one or more subsidiaries), (B)&nbsp;no Organization (excluding any entity resulting from such transaction or any Benefit Plan of the
Company or such entity resulting from such transaction) beneficially owns, directly or indirectly, 50% or more of the combined voting power of the then outstanding voting securities of such entity, and (C)&nbsp;at least a majority of the members of
the board of directors or similar board of the entity resulting from such transaction were members of the Incumbent Board at the time of the execution of the initial agreement, or of the action of the Board, approving such transaction; or
(iv)&nbsp;approval by the stockholders of the Company of a complete liquidation or dissolution of the Company. For purposes of the Plan: &#147;<B>Benefit Plan</B>&#148; means any employee benefit plan, including any related trust;
&#147;<B>Board</B>&#148; means the Board of Directors of the Company; &#147;<B>Exchange Act</B>&#148; means the Securities Exchange Act of 1934, as amended; and &#147;<B>Organization</B>&#148; means any individual, entity or group (within the
meaning of Section&nbsp;13(d)(3) or Section&nbsp;14(d)(2) of the Exchange Act) excluding, for this purpose, the Company and its Affiliates as of the Effective Date. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(d) &#147;<B>Company</B>&#148; means MiNK Therapeutics, Inc., a Delaware corporation, and any successor in interest to the Company. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(e) &#147;<B>Compensation Committee</B>&#148; means the compensation committee of the Board. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(f) &#147;<B>ERISA</B>&#148; means the Employee Retirement Income Security Act of 1974, as amended. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(g) &#147;<B>Executive</B>&#148; means each employee of the Company specifically designated by the Compensation Committee (or an individual
specifically appointed by the Compensation Committee to make such determination) as eligible to participate in the Plan, provided such individual holds the position of Vice President or above in the Company, or is otherwise identified as an
essential employee of the Company by the Compensation Committee. </P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(h) &#147;<B>Good Reason</B>&#148; means, in each case, without Executive&#146;s written
consent, (i)&nbsp;a material reduction in Executive&#146;s base salary, target incentive bonus, duties or responsibilities; or (ii)&nbsp;a relocation of Executive&#146;s principal office, without his/her consent, to a location more than thirty
(30)&nbsp;miles from its location on the day prior to the Change of Control; provided that (A)&nbsp;Executive provides written notice to the Company, setting forth in reasonable detail the nature of the condition giving rise to Good Reason, within
thirty (30)&nbsp;days of the initial existence of such condition, (B)&nbsp;the condition remains uncured by the Company for a period of thirty (30)&nbsp;days following such notice and (C)&nbsp;Executive terminates his employment, if at all, not
later than thirty (30)&nbsp;days after the expiration of such cure period. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(i) &#147;<B>Person</B>&#148; means an individual, a
corporation, an association, a partnership, an estate, a trust and any other entity or organization, other than the Company or any of its Affiliates. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(j) &#147;<B>Products</B>&#148; mean all products planned, researched, developed, under development, tested, manufactured, sold, licensed,
leased or otherwise distributed or put into use by the Company or any of its Affiliates, together with all services provided or planned by the Company or any of its Affiliates, during Executive&#146;s employment. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">2. <U>Change of Control</U>. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(a)
If, on or after the Effective Date, a Change of Control occurs, on the date of such Change of Control, notwithstanding the terms of the Company&#146;s equity incentive plan under which Executive&#146;s equity awards were granted or any applicable
award agreements evidencing such awards, fifty-percent (50%)&nbsp;of any stock options, restricted stock units or shares of restricted stock of the Company previously granted or issued to Executive that are outstanding and unvested as of the date of
the Change of Control and for which vesting is solely based on the passage of time shall become vested, exercisable and, in the case of shares of restricted stock, no longer subject to forfeiture, provided that Executive is employed by the Company
on the date of such Change of Control. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b) If, on or after the Effective Date, a Change of Control occurs and, within eighteen
(18)&nbsp;months following such Change of Control, the Company terminates Executive&#146;s employment other than for Cause (not including as a result of Executive&#146;s death or long-term disability), or such Executive terminates his/her employment
for Good Reason, then the Company shall pay to Executive in one lump sum an amount equal to (i)&nbsp;twelve (12) months base salary at the rate in effect on the date of termination of employment (or, if greater, as in effect prior to any reduction
to such base salary following the Change of Control), plus (ii)&nbsp;an amount equal to the higher of (A)&nbsp;Executive&#146;s target incentive bonus for the year in which Executive&#146;s employment terminates (or, if greater, as in effect prior
to any reduction to such target incentive bonus following the Change of Control), or (B)&nbsp;the actual incentive bonus paid to Executive, if any, under the Company&#146;s incentive plan for the last full fiscal year preceding the year in which
Executive&#146;s employment terminates; and, if Executive timely elects COBRA continuation coverage, the Company shall also pay the employer portion of the group medical and dental premium payments as in effect on the date of the termination of
employment for Executive and his/her qualified dependents until the earlier of (i)&nbsp;the end of the twelve (12)-month period following the date of termination of employment, or (ii)&nbsp;the date on which Executive ceases to be eligible for COBRA
continuation coverage for any reason or such coverage otherwise terminates. If Executive timely elects COBRA </P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
continuation coverage and the Company concludes that the foregoing arrangement could result in additional taxes or penalties for either Executive or the Company on account of the rules under
Section&nbsp;105(h) of the Internal Revenue Code, then in lieu of this continued subsidized coverage, Executive shall be provided with an additional severance payment equal to the value of this employer-provided subsidy for the twelve (12)-month
period following the date of termination, plus an additional <FONT STYLE="white-space:nowrap">lump-sum</FONT> payment in an amount sufficient, after giving effect to all federal, state and other taxes with respect to such additional payment, to make
Executive whole for all taxes (including withholding taxes) on such payment.<B> </B>In addition, in the event the Company terminates Executive&#146;s employment other than for Cause (not including as a result of Executive&#146;s death or long-term
disability), or Executive terminates his/her employment for Good Reason within eighteen (18)&nbsp;months following a Change of Control, then, notwithstanding the terms of the Company&#146;s equity incentive plan under which Executive&#146;s equity
awards were granted or any applicable award agreements evidencing such awards, (I)&nbsp;any outstanding unvested options granted or issued to Executive as of the date of the Change of Control shall become vested and shall be exercisable for ninety
(90)&nbsp;days following termination of Executive&#146;s employment (but not following the original term of such options), (II) any shares of unvested restricted stock of the Company or unvested restricted stock units granted or issued to Executive
as of the date of the Change of Control shall become vested and no longer subject to forfeiture (in the case of restricted stock), in the case of (I)&nbsp;and (II), assuming that any performance vesting conditions associated with a grant of options,
restricted stock or restricted stock units are satisfied, and (III)&nbsp;the Company will provide Executive with an outplacement benefit in the form of a <FONT STYLE="white-space:nowrap">lump-sum</FONT> payment of $10,000 plus an additional <FONT
STYLE="white-space:nowrap">lump-sum</FONT> payment in an amount sufficient, after giving effect to all federal, state and other taxes with respect to such additional payment, to make Executive whole for all taxes (including withholding taxes) on
such outplacement assistance benefit. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(c) All payments required to be made by the Company hereunder to Executive or his/her dependents,
beneficiaries, or estate will be reduced by any tax, payroll deductions or other amounts required to be withheld by the Company under applicable law or regulation. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(d) The payments and benefits contemplated by Section&nbsp;2(a) and the contributions to the cost of Executive&#146;s continued participation
in the Company&#146;s group health and dental plans that may be due Executive under Section&nbsp;2(b) shall constitute the entire obligation of the Company to Executive. In order to receive and retain any payments or other benefits under
Section&nbsp;2(b), Executive must execute a general release of claims (the &#147;<B>Release</B>&#148;) in a form acceptable to the Company and Executive must continue to comply with any agreement between Executive and the Company or any of its
Affiliates that includes <FONT STYLE="white-space:nowrap">non-competition,</FONT> <FONT STYLE="white-space:nowrap">non-solicitation</FONT> and/or confidentiality restrictions, including, for the avoidance of doubt, any restrictive covenants
contained in any Participation Agreement (the &#147;<B>Restrictive Covenants</B>&#148;). The severance payments and benefits payable under the Plan shall be subject to forfeiture, clawback and/or recoupment by the Company automatically upon
Executive&#146;s breach of any Restrictive Covenants. </P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(e) Except for medical and dental insurance coverage continued pursuant to
Section&nbsp;2(b), benefits shall terminate pursuant to the terms of the applicable benefit plans based on the date of termination of Executive&#146;s employment without regard to any continuation of base salary or other payment to Executive
following such date of termination. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(f) The obligation of the Company to make payments to or on behalf of Executive under
Section&nbsp;2(b) is expressly conditioned upon Executive&#146;s continued full performance of obligations under the Plan and Executive&#146;s Participation Agreement. Executive recognizes that, except as expressly provided in Section&nbsp;2(b), no
compensation is earned by, or in any way owing to, Executive after termination of employment. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">3. <U>Timing of Payments;
Section</U><U></U><U>&nbsp;409A</U>. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(a) The Plan is intended to comply with Section&nbsp;409A of the Internal Revenue Code
(&#147;<B>Section</B><B></B><B>&nbsp;409A</B>&#148;) or an exemption thereunder and the Plan (including all Participation Agreements) shall be construed and administered in accordance with Section&nbsp;409A. Any payments under the Plan that may be
exempt under Section&nbsp;409A either as separation pay due to an involuntary separation from service or as a short-term deferral shall be treated as exempt under Section&nbsp;409A to the maximum extent possible. For purposes of Section&nbsp;409A,
references to termination of employment will be interpreted consistent with the definition of &#147;separation from service&#148; in Section&nbsp;409A, to the extent required under Section&nbsp;409A, and each installment in a series of payments will
be treated as a separate &#147;payment.&#148; Notwithstanding any other provision of the Plan (including any Participation Agreement), if any payment or benefit is conditioned on Executive&#146;s execution of a Release, the first payment shall
include all amounts that would otherwise have been paid to Executive during the period beginning on the date of the termination of employment and ending on the payment date if no delay had been imposed and shall be made (or commence to be made in
the case of any health continuation benefits or shall become effective in the case of any accelerated vesting or exercisability of equity awards), in all cases subject to the next sentence, on the first payroll period following the date that the
release becomes effective, but no later than sixty (60)&nbsp;days following the date of Executive&#146;s termination of employment. If the period within which Executive must execute a Release begins in one calendar year and expires in the following
calendar year, then any payments contingent upon the execution of a Release shall be made in such following calendar year (regardless of the year of execution of the Release) if the payment in such following calendar year is required to avoid
penalty under Section&nbsp;409A. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b) Notwithstanding anything to the contrary in the Plan (including any Participation Agreement), if at
the time of an Executive&#146;s termination of employment, Executive is a &#147;specified employee,&#148; as defined below, any and all amounts payable under the Plan on account of such separation from service that are covered in (i)&nbsp;below that
would (but for this provision) be payable within six (6)&nbsp;months following the date of termination, will instead be paid on the next business day following the expiration of such six (6)&nbsp;month period or, if earlier, upon Executive&#146;s
death; except (i)&nbsp;to the extent of amounts that do not constitute a deferral of compensation within the meaning of Treasury </P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
Regulation <FONT STYLE="white-space:nowrap">Section&nbsp;1.409A-1(b)</FONT> (including without limitation by reason of the safe harbor set forth in
<FONT STYLE="white-space:nowrap">Section&nbsp;1.409A-1(b)(9)(iii),</FONT> as determined by the Company in its reasonable good faith discretion); (ii) benefits that qualify as excepted welfare benefits pursuant to Treasury Regulation <FONT
STYLE="white-space:nowrap">Section&nbsp;1.409A-1(a)(5);</FONT> or (iii)&nbsp;other amounts or benefits that are not subject to the requirements of Section&nbsp;409A. Notwithstanding the foregoing, the Company makes no representations that the
payments and benefits provided under the Plan comply with Section&nbsp;409A and in no event shall the Company be liable for all or any portion of any taxes, penalties, interest or other expenses that may be incurred by an Executive on account of <FONT
STYLE="white-space:nowrap">non-compliance</FONT> with Section&nbsp;409A. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">4. <U>Section</U><U></U><U>&nbsp;280G of the Internal Revenue
Code</U>. Notwithstanding anything in the Plan to the contrary (including any Participation Agreement), if at any time it is determined that payment of the benefits described herein, either alone or together with any other payments and benefits
payable to an Executive (the &#147;<B>280G Payments</B>&#148;), would constitute &#147;parachute payments&#148; within the meaning of Section&nbsp;280G of the Internal Revenue Code and would, but for this paragraph, be subject to the excise tax
imposed under Section&nbsp;4999 of the Internal Revenue Code (the &#147;<B>Excise Tax</B>&#148;), then such 280G Payments will be reduced by the Company by first reducing or eliminating payments that are payable in cash and then by reducing or
eliminating payments, rights, and benefits that are not payable in cash, in each case, in reverse order beginning with payments, rights, or benefits that are to be paid farthest in time from the termination of employment or the Change of Control, as
applicable, so that Executive will not be subject to the Excise Tax; <U>provided</U> that such reduction or elimination will not apply if Executive would receive a greater <FONT STYLE="white-space:nowrap">after-tax</FONT> amount by receiving all
such 280G Payments without reduction or elimination pursuant to the foregoing provisions of this sentence.<SUP STYLE="font-size:85%; vertical-align:top"> </SUP>In the event that an Executive receives payments or benefits that should not have been
paid under this paragraph, Executive must repay or reimburse the Company promptly upon receiving notice that an overpayment has been made. Nothing in the Plan or any Participation Agreement will cause the Company to be responsible for, or to have
any liability or obligation with respect to, the Excise Tax, including, but not limited to providing any <FONT STYLE="white-space:nowrap">gross-up</FONT> or payment for such tax. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">5. <U>Amendment</U>. The Plan may be amended, modified or terminated by the Compensation Committee in its sole discretion prior to the
occurrence of a Change in Control; <U>provided</U>, that no such amendment, modification or termination shall be effective with respect to any Executive that has executed a Participation Agreement if such action would materially and adversely affect
the interests of Executive, except to the extent such Executive has agreed in writing to be bound by such amendment, modification or termination; and <U>provided</U> <U>further</U>, that during the eighteen (18)-month period following the
consummation of a Change in Control, (a)&nbsp;the Plan may not be terminated and (b)&nbsp;the Plan may not be amended if such amendment would in any manner be adverse to the interests of an Executive. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">6. <U>Unfunded Plan</U>. The Plan is unfunded, and payments and benefits hereunder are payable from the general assets of the Company. The Plan
is unfunded and is intended to be an &#147;employee welfare benefit plan&#148; (within the meaning of Section&nbsp;3(1) of ERISA), maintained for the purpose of providing benefits to a select group of management or highly compensated employees and
shall be administered and construed in accordance with <U>Appendix A</U>. </P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">7. <U>Governing Law</U>. This is Plan shall be construed and enforced under and be governed
in all respects by the laws of the State of New York, without regard to the conflict of laws principles thereof. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right"><I>Adopted by the Board of
Directors</I> &#150; June&nbsp;8, 2022 </P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><U>Appendix A </U></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>CLAIMS, INQUIRIES AND APPEALS </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(a) <U>Claims for Benefits and Inquiries</U>. Any claim for benefits, request for review, inquiries about the Plan or inquiries about present
or future rights under the Plan must be submitted to the Compensation Committee in writing by an Executive (or his or her authorized representative) at the following address: </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">MiNK Therapeutics, Inc. </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">149 Fifth
Avenue Suite 500 </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">New York, NY 10010 </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">Attn: Chairman of the Compensation Committee of the Board </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b) <U>Denial of Claims</U>. In the event that any claim for benefits is denied in whole or in part, the Compensation Committee must provide
the claimant with written or electronic notice of the denial of the claim, and of the claimant&#146;s right to review the denial. Any electronic notice will comply with the regulations of the U.S. Department of Labor. The notice of denial will be
set forth in a manner designed to be understood by the claimant and will include the following: </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(i) the specific reason or reasons for
the denial; </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(ii) references to the specific Plan provisions upon which the denial is based; </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(iii) a description of any additional information or material that the Compensation Committee needs to complete the review and an explanation
of why such information or material is necessary; and </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(iv) an explanation of the Compensation Committee&#146;s review procedures and the
time limits applicable to such procedures, including a statement of the claimant&#146;s right to bring a civil action under Section&nbsp;502(a) of ERISA following a denial on review of the claim, as described in (d)&nbsp;below. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">This notice of denial will be given to the claimant within ninety (90)&nbsp;days after the Compensation Committee receives the claim, unless
special circumstances require an extension of time, in which case, the Compensation Committee has up to an additional ninety (90)&nbsp;days for processing the claim. If an extension of time for processing is required, written notice of the extension
will be furnished to the claimant before the end of the initial ninety (90)&nbsp;day period. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">This notice of extension will describe the
special circumstances necessitating the additional time and the date by which the Compensation Committee is to render its decision on the claim. </P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(c) <U>Request for a Review</U>. Any person (or that person&#146;s authorized
representative) for whom a claim for benefits is denied, in whole or in part, may appeal the denial by submitting a request for a review to the Compensation Committee within sixty (60)&nbsp;days after the claim is denied. A request for a review
shall be in writing and shall be sent to the address set forth above. A request for review must set forth all of the grounds on which it is based, all facts in support of the request and any other matters that the claimant feels are pertinent. The
claimant (or his or her representative) shall have the opportunity to submit (or the Compensation Committee may require the claimant to submit) written comments, documents, records, and other information relating to his or her claim. The claimant
(or his or her representative) shall be provided, upon request and free of charge, reasonable access to, and copies of, all documents, records and other information relevant to his or her claim. The review shall take into account all comments,
documents, records and other information submitted by the claimant (or his or her representative) relating to the claim, without regard to whether such information was submitted or considered in the initial benefit determination. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(d) <U>Decision on Review</U>. The Compensation Committee will act on each request for review within sixty (60)&nbsp;days after receipt of the
request, unless special circumstances require an extension of time (not to exceed an additional sixty (60)&nbsp;days), for processing the request for a review. If an extension for review is required, written notice of the extension will be furnished
to the claimant within the initial sixty (60)&nbsp;day period. This notice of extension will describe the special circumstances necessitating the additional time and the date by which the Compensation Committee is to render its decision on the
review. The Compensation Committee will give prompt, written or electronic notice of its decision to the claimant. Any electronic notice will comply with the regulations of the U.S. Department of Labor. In the event that the Compensation Committee
confirms the denial of the claimant for benefits in whole or in part, the notice will set forth, in a manner calculated to be understood by the claimant, the following: </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(i) the specific reason or reasons for the denial; </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(ii) references to the specific Plan provisions upon which the denial is based; </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(iii) a statement that the claimant is entitled to receive, upon request and free of charge, reasonable access to, and copies of, all
documents, records and other information relevant to his or her claim; and </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(iv) a statement of the claimant&#146;s right to bring a civil
action under Section&nbsp;502(a) of ERISA. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(e) <U>Rules and Procedures</U>. The Compensation Committee will establish rules and
procedures, consistent with the Plan and with ERISA, as necessary and appropriate in carrying out its responsibilities in reviewing benefit claims. The Compensation Committee may require a claimant who wishes to submit additional information in
connection with an appeal from the denial of benefits to do so at the claimant&#146;s own expense. </P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(f) <U>Exhaustion of Remedies</U>. No legal action for benefits under the Plan may be
brought until the claimant (i)&nbsp;has submitted a written claim for benefits in accordance with the procedures described by (a)&nbsp;above, (ii) has been notified by the Compensation Committee that the claim is denied, (iii)&nbsp;has filed a
written request for a review of the claim in accordance with the appeal procedure described in (c)&nbsp;above, and (iv)&nbsp;has been notified that the Compensation Committee has denied the appeal. Notwithstanding the foregoing, if the Compensation
Committee does not respond to an Executive&#146;s claim or appeal within the relevant time limits specified in this <U>Appendix A</U>, Executive may bring legal action for benefits under the Plan pursuant to Section&nbsp;502(a) of ERISA. In no event
may any legal proceeding regarding entitlement to benefits or any aspect of benefits under the Plan be commenced later than the earlier of: (i)&nbsp;one year after the date on which the claimant receives a decision from the Compensation Committee
regarding his or her appeal; and (ii)&nbsp;the date otherwise prescribed by applicable law. </P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><U>Exhibit A </U></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>EXECUTIVE CHANGE OF CONTROL PLAN </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><U>Participation Agreement </U></B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">Executive signing below hereby wishes to participate in the Executive Change of Control Plan of MiNK Therapeutics, Inc. (as it may be amended
from time to time, the &#147;<B>Plan</B>&#148;). In order for Executive to participate in the Plan, Executive must agree to the restrictions on his/her activities during and after his/her employment as provided in this Participation Agreement. Any
capitalized terms used in this Participation Agreement and not defined shall have the meaning set forth in the Plan. By signing below, the Company and Executive agree as follows: </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">1. <U>Participation in the Plan</U>. Executive shall be entitled to participate in the Plan on the terms and conditions provided for in the Plan and this
Participation Agreement, as the same may be amended from time to time. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">2. <U><FONT STYLE="white-space:nowrap">Non-competition</FONT></U>. While Executive
is employed by the Company and for the greater of (i)&nbsp;twelve (12)&nbsp;months after his/her employment terminates or (ii)&nbsp;the period during which Executive is receiving payments or benefits under the Plan (the &#147;<B><FONT
STYLE="white-space:nowrap">Non-Competition</FONT> Period</B>&#148;), Executive shall not, directly or indirectly, whether as owner, partner, investor, consultant, agent, employee, co-venturer or otherwise, compete with the Company or any of its
Affiliates or undertake any planning for any business competitive with the Company or any of its Affiliates. Specifically, but without limiting the foregoing, Executive agrees not to engage in any manner in any activity that is directly or
indirectly competitive with the business of the Company or any of its Affiliates as conducted or under consideration at any time during Executive&#146;s employment. Restricted activity includes, without limitation, accepting employment or a
consulting position with any Person who is, or at any time within twelve (12)&nbsp;months prior to termination of Executive&#146;s employment has been, a competitor or a customer of the Company or any of its Affiliates. For the purposes of this
Section&nbsp;2, the business of the Company and its Affiliates shall include all Products and Executive&#146;s undertaking shall encompass all items, products and services that may be used in substitution for Products. The foregoing shall not
prohibit Executive&#146;s passive ownership of two percent (2%)&nbsp;or less of the equity securities of any publicly traded company. Executive agrees that, during his/her employment with the Company or any Affiliate of the Company, he/she will not
undertake any outside activity, whether or not competitive with the business of the Company or its Affiliates, that could reasonably give rise to a conflict of interest or otherwise interfere with his/her duties and obligations to the Company or any
of its Affiliates. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">3. <U><FONT STYLE="white-space:nowrap">Non-solicitation</FONT></U>. Executive further agrees that while he/she is employed by the
Company or any Affiliate of the Company and thereafter during the <FONT STYLE="white-space:nowrap">Non-Competition</FONT> Period, Executive will not hire or attempt to hire any employee of the Company or any of its Affiliates, assist in such hiring
by any Person, encourage any such employee to terminate his or her relationship with the Company or any of its Affiliates, or solicit or encourage any customer or vendor of the Company or any of its Affiliates to terminate its relationship with
them, or, in the case of a customer, to conduct with any Person any business or activity which such customer conducts or could conduct with the Company or any of its Affiliates. </P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">4. <U>Conflicting Agreements</U>. Executive hereby represents and warrants that the execution of this
Participation Agreement, participation in the Plan and the performance of his/her obligations hereunder will not breach or be in conflict with any other agreement to which Executive is a party or is bound. In addition, except where specifically
provided in the Plan or this Participation Agreement, nothing in the Plan or this Participation Agreement is intended to replace, amend or modify any other agreement between the Company and Executive, and to the extent such other agreements contain
similar provisions to those provided for in this Participation Agreement, such provisions shall be in addition to the provisions provided herein and shall remain in effect. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">5. <U>Notification Requirement</U>. Until the conclusion of the <FONT STYLE="white-space:nowrap">Non-Competition</FONT> Period, Executive shall give notice to
the Company of each new business activity he/she plans to undertake, at least <FONT STYLE="white-space:nowrap">twenty-one</FONT> (21)&nbsp;days prior to beginning any such activity. Such notice shall state the name and address of the Person for whom
such activity is undertaken and the nature of Executive&#146;s business relationship(s) and position(s) with such Person. Executive shall provide the Company with such other pertinent information concerning such business activity as the Company may
reasonably request in order to determine Executive&#146;s continued compliance with this Participation Agreement and the Plan. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">6. <U>Enforcement of
Covenants</U>. Executive acknowledges that he/she has carefully read and considered all the terms and conditions of this Participation Agreement, including the restraints imposed upon him/her pursuant to the Plan and this Participation Agreement.
Executive agrees that said restraints are necessary for the reasonable and proper protection of the Company and its Affiliates and that each and every one of the restraints is reasonable in respect to subject matter, length of time and geographic
area. Executive further acknowledges that, were he/she to breach any of his/her covenants contained in the Plan or this Participation Agreement, the damage to the Company would be irreparable. Executive therefore agrees that the Company, in addition
to any other remedies available to it, shall be entitled to preliminary and permanent injunctive relief against any breach or threatened breach by Executive of any of said covenants, without having to post bond. The parties further agree that, in
the event that any provision of Sections 2 and 3 hereof shall be determined by any court of competent jurisdiction to be unenforceable by reason of its being extended over too great a time, too large a geographic area or too great a range of
activities, such provision shall be deemed to be modified to permit its enforcement to the maximum extent permitted by law. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">7. <U>General</U>. This
Participation Agreement may be amended or modified by execution of an amendment signed by Executive and the Company. This Participation Agreement and the Plan shall be construed and enforced under and be governed in all respects by the laws of the
State of New York, without regard to the conflict of laws principles thereof. </P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><I>[Remainder of page intentionally left blank.] </I></P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">IN WITNESS WHEREOF, this Participation Agreement has been executed as a sealed instrument by the Company, by
its duly authorized representative, and by Executive, as of _________________, _____. </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>

<TD WIDTH="44%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="4%"></TD>

<TD VALIGN="bottom"></TD>
<TD WIDTH="5%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="44%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">EXECUTIVE:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" COLSPAN="3">MINK THERAPEUTICS, INC., a Delaware corporation</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">&nbsp;</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">By:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"><B>[NAME OF EXECUTIVE]</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Name:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Title:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</P></TD></TR>
</TABLE>
</DIV></Center>

</BODY></HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>3
<FILENAME>inkt-20220608.xsd
<DESCRIPTION>XBRL TAXONOMY EXTENSION SCHEMA
<TEXT>
<XBRL>
<?xml version="1.0" encoding="us-ascii"?>
<!-- DFIN - https://www.dfinsolutions.com/ -->
<!-- CTU Version: Release master Build:20220115.12 -->
<!-- Creation date: 6/14/2022 11:10:15 PM Eastern Time -->
<!-- Copyright (c) 2022 Donnelley Financial Solutions, Inc. All Rights Reserved. -->
<xsd:schema
  xmlns:nonnum="http://www.xbrl.org/dtr/type/non-numeric"
  xmlns:num="http://www.xbrl.org/dtr/type/numeric"
  xmlns:us-types="http://fasb.org/us-types/2021-01-31"
  xmlns:inkt="http://minktherapeutics.com/20220608"
  xmlns:dei="http://xbrl.sec.gov/dei/2021"
  xmlns:xbrli="http://www.xbrl.org/2003/instance"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:xlink="http://www.w3.org/1999/xlink"
  xmlns:xbrldt="http://xbrl.org/2005/xbrldt"
  attributeFormDefault="unqualified"
  elementFormDefault="qualified"
  targetNamespace="http://minktherapeutics.com/20220608"
  xmlns:xsd="http://www.w3.org/2001/XMLSchema">
    <xsd:import schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd" namespace="http://www.xbrl.org/2003/instance" />
    <xsd:import schemaLocation="http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd" namespace="http://www.xbrl.org/2003/linkbase" />
    <xsd:import schemaLocation="https://xbrl.sec.gov/dei/2021/dei-2021.xsd" namespace="http://xbrl.sec.gov/dei/2021" />
    <xsd:import schemaLocation="http://www.xbrl.org/dtr/type/numeric-2009-12-16.xsd" namespace="http://www.xbrl.org/dtr/type/numeric" />
    <xsd:import schemaLocation="http://www.xbrl.org/dtr/type/nonNumeric-2009-12-16.xsd" namespace="http://www.xbrl.org/dtr/type/non-numeric" />
    <xsd:import schemaLocation="https://xbrl.sec.gov/naics/2021/naics-2021.xsd" namespace="http://xbrl.sec.gov/naics/2021" />
    <xsd:import schemaLocation="http://www.xbrl.org/2005/xbrldt-2005.xsd" namespace="http://xbrl.org/2005/xbrldt" />
  <xsd:annotation>
    <xsd:appinfo>
      <link:linkbaseRef xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="inkt-20220608_lab.xml" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:title="Label Links, all" xlink:type="simple" />
      <link:linkbaseRef xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="inkt-20220608_pre.xml" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:title="Presentation Links, all" xlink:type="simple" />
      <link:roleType roleURI="http://minktherapeutics.com//20220608/taxonomy/role/DocumentDocumentAndEntityInformation" id="Role_DocumentDocumentAndEntityInformation">
        <link:definition>100000 - Document - Document and Entity Information</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
    </xsd:appinfo>
  </xsd:annotation>
</xsd:schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.LAB
<SEQUENCE>4
<FILENAME>inkt-20220608_lab.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION LABEL LINKBASE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="us-ascii" standalone="yes"?>
<!-- DFIN - https://www.dfinsolutions.com/ -->
<!-- CTU Version: Release master Build:20220115.12 -->
<!-- Creation date: 6/14/2022 11:10:15 PM Eastern Time -->
<!-- Copyright (c) 2022 Donnelley Financial Solutions, Inc. All Rights Reserved. -->
<link:linkbase
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:xlink="http://www.w3.org/1999/xlink"
  xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"
  xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:labelLink xlink:role="http://www.xbrl.org/2003/role/link" xlink:type="extended">
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_CoverAbstract" xlink:type="locator" xlink:label="dei_CoverAbstract" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CoverAbstract" xlink:to="dei_CoverAbstract_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_CoverAbstract_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Cover [Abstract]</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_CoverAbstract_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Cover [Abstract]</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_SecurityExchangeName" xlink:type="locator" xlink:label="dei_SecurityExchangeName" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SecurityExchangeName" xlink:to="dei_SecurityExchangeName_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_SecurityExchangeName_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Security Exchange Name</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_SecurityExchangeName_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Security Exchange Name</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_AmendmentFlag" xlink:type="locator" xlink:label="dei_AmendmentFlag" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AmendmentFlag" xlink:to="dei_AmendmentFlag_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_AmendmentFlag_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Amendment Flag</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_AmendmentFlag_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Amendment Flag</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityCentralIndexKey" xlink:type="locator" xlink:label="dei_EntityCentralIndexKey" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCentralIndexKey" xlink:to="dei_EntityCentralIndexKey_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityCentralIndexKey_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Central Index Key</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityCentralIndexKey_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Central Index Key</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_DocumentType" xlink:type="locator" xlink:label="dei_DocumentType" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentType" xlink:to="dei_DocumentType_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_DocumentType_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Document Type</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_DocumentType_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Document Type</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_DocumentPeriodEndDate" xlink:type="locator" xlink:label="dei_DocumentPeriodEndDate" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentPeriodEndDate" xlink:to="dei_DocumentPeriodEndDate_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_DocumentPeriodEndDate_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Document Period End Date</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_DocumentPeriodEndDate_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Document Period End Date</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityRegistrantName" xlink:type="locator" xlink:label="dei_EntityRegistrantName" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityRegistrantName" xlink:to="dei_EntityRegistrantName_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityRegistrantName_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Registrant Name</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityRegistrantName_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Registrant Name</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityIncorporationStateCountryCode" xlink:type="locator" xlink:label="dei_EntityIncorporationStateCountryCode" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityIncorporationStateCountryCode" xlink:to="dei_EntityIncorporationStateCountryCode_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityIncorporationStateCountryCode_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Incorporation State Country Code</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityIncorporationStateCountryCode_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Incorporation State Country Code</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityFileNumber" xlink:type="locator" xlink:label="dei_EntityFileNumber" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityFileNumber" xlink:to="dei_EntityFileNumber_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityFileNumber_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity File Number</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityFileNumber_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity File Number</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityTaxIdentificationNumber" xlink:type="locator" xlink:label="dei_EntityTaxIdentificationNumber" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityTaxIdentificationNumber" xlink:to="dei_EntityTaxIdentificationNumber_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityTaxIdentificationNumber_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Tax Identification Number</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityTaxIdentificationNumber_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Tax Identification Number</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityAddressAddressLine1" xlink:type="locator" xlink:label="dei_EntityAddressAddressLine1" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine1" xlink:to="dei_EntityAddressAddressLine1_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressAddressLine1_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Address, Address Line One</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressAddressLine1_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Address, Address Line One</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityAddressAddressLine2" xlink:type="locator" xlink:label="dei_EntityAddressAddressLine2" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine2" xlink:to="dei_EntityAddressAddressLine2_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressAddressLine2_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Address, Address Line Two</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressAddressLine2_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Address, Address Line Two</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityAddressCityOrTown" xlink:type="locator" xlink:label="dei_EntityAddressCityOrTown" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressCityOrTown" xlink:to="dei_EntityAddressCityOrTown_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressCityOrTown_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Address, City or Town</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressCityOrTown_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Address, City or Town</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityAddressStateOrProvince" xlink:type="locator" xlink:label="dei_EntityAddressStateOrProvince" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressStateOrProvince" xlink:to="dei_EntityAddressStateOrProvince_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressStateOrProvince_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Address, State or Province</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressStateOrProvince_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Address, State or Province</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityAddressPostalZipCode" xlink:type="locator" xlink:label="dei_EntityAddressPostalZipCode" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressPostalZipCode" xlink:to="dei_EntityAddressPostalZipCode_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressPostalZipCode_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Address, Postal Zip Code</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressPostalZipCode_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Address, Postal Zip Code</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_CityAreaCode" xlink:type="locator" xlink:label="dei_CityAreaCode" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CityAreaCode" xlink:to="dei_CityAreaCode_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_CityAreaCode_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">City Area Code</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_CityAreaCode_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">City Area Code</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_LocalPhoneNumber" xlink:type="locator" xlink:label="dei_LocalPhoneNumber" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_LocalPhoneNumber" xlink:to="dei_LocalPhoneNumber_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_LocalPhoneNumber_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Local Phone Number</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_LocalPhoneNumber_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Local Phone Number</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_WrittenCommunications" xlink:type="locator" xlink:label="dei_WrittenCommunications" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_WrittenCommunications" xlink:to="dei_WrittenCommunications_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_WrittenCommunications_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Written Communications</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_WrittenCommunications_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Written Communications</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_SolicitingMaterial" xlink:type="locator" xlink:label="dei_SolicitingMaterial" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SolicitingMaterial" xlink:to="dei_SolicitingMaterial_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_SolicitingMaterial_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Soliciting Material</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_SolicitingMaterial_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Soliciting Material</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_PreCommencementTenderOffer" xlink:type="locator" xlink:label="dei_PreCommencementTenderOffer" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_PreCommencementTenderOffer" xlink:to="dei_PreCommencementTenderOffer_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_PreCommencementTenderOffer_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Pre Commencement Tender Offer</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_PreCommencementTenderOffer_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Pre Commencement Tender Offer</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_PreCommencementIssuerTenderOffer" xlink:type="locator" xlink:label="dei_PreCommencementIssuerTenderOffer" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_PreCommencementIssuerTenderOffer" xlink:to="dei_PreCommencementIssuerTenderOffer_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_PreCommencementIssuerTenderOffer_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Pre Commencement Issuer Tender Offer</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_PreCommencementIssuerTenderOffer_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Pre Commencement Issuer Tender Offer</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_Security12bTitle" xlink:type="locator" xlink:label="dei_Security12bTitle" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_Security12bTitle" xlink:to="dei_Security12bTitle_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_Security12bTitle_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Security 12b Title</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_Security12bTitle_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Security 12b Title</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_TradingSymbol" xlink:type="locator" xlink:label="dei_TradingSymbol" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_TradingSymbol" xlink:to="dei_TradingSymbol_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_TradingSymbol_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Trading Symbol</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_TradingSymbol_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Trading Symbol</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityEmergingGrowthCompany" xlink:type="locator" xlink:label="dei_EntityEmergingGrowthCompany" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityEmergingGrowthCompany" xlink:to="dei_EntityEmergingGrowthCompany_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityEmergingGrowthCompany_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Emerging Growth Company</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityEmergingGrowthCompany_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Emerging Growth Company</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityExTransitionPeriod" xlink:type="locator" xlink:label="dei_EntityExTransitionPeriod" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityExTransitionPeriod" xlink:to="dei_EntityExTransitionPeriod_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityExTransitionPeriod_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Ex Transition Period</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityExTransitionPeriod_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Ex Transition Period</link:label>
  </link:labelLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.PRE
<SEQUENCE>5
<FILENAME>inkt-20220608_pre.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="us-ascii" standalone="yes"?>
<!-- DFIN - https://www.dfinsolutions.com/ -->
<!-- CTU Version: Release master Build:20220115.12 -->
<!-- Creation date: 6/14/2022 11:10:15 PM Eastern Time -->
<!-- Copyright (c) 2022 Donnelley Financial Solutions, Inc. All Rights Reserved. -->
<link:linkbase
    xmlns:link="http://www.xbrl.org/2003/linkbase"
    xmlns:xlink="http://www.w3.org/1999/xlink"
    xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"
    xmlns:xbrldt="http://xbrl.org/2005/xbrldt"
    xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://minktherapeutics.com//20220608/taxonomy/role/DocumentDocumentAndEntityInformation" xlink:href="inkt-20220608.xsd#Role_DocumentDocumentAndEntityInformation" xlink:type="simple" />
  <link:presentationLink xlink:type="extended" xlink:role="http://minktherapeutics.com//20220608/taxonomy/role/DocumentDocumentAndEntityInformation">
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_CoverAbstract" xlink:type="locator" xlink:label="dei_CoverAbstract" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_SecurityExchangeName" xlink:type="locator" xlink:label="dei_SecurityExchangeName" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_SecurityExchangeName" order="22.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_AmendmentFlag" xlink:type="locator" xlink:label="dei_AmendmentFlag" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_AmendmentFlag" order="23.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityCentralIndexKey" xlink:type="locator" xlink:label="dei_EntityCentralIndexKey" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityCentralIndexKey" order="24.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_DocumentType" xlink:type="locator" xlink:label="dei_DocumentType" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_DocumentType" order="26.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_DocumentPeriodEndDate" xlink:type="locator" xlink:label="dei_DocumentPeriodEndDate" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_DocumentPeriodEndDate" order="27.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityRegistrantName" xlink:type="locator" xlink:label="dei_EntityRegistrantName" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityRegistrantName" order="28.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityIncorporationStateCountryCode" xlink:type="locator" xlink:label="dei_EntityIncorporationStateCountryCode" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityIncorporationStateCountryCode" order="29.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityFileNumber" xlink:type="locator" xlink:label="dei_EntityFileNumber" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityFileNumber" order="30.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityTaxIdentificationNumber" xlink:type="locator" xlink:label="dei_EntityTaxIdentificationNumber" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityTaxIdentificationNumber" order="31.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityAddressAddressLine1" xlink:type="locator" xlink:label="dei_EntityAddressAddressLine1" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityAddressAddressLine1" order="32.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityAddressAddressLine2" xlink:type="locator" xlink:label="dei_EntityAddressAddressLine2" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityAddressAddressLine2" order="33.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityAddressCityOrTown" xlink:type="locator" xlink:label="dei_EntityAddressCityOrTown" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityAddressCityOrTown" order="34.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityAddressStateOrProvince" xlink:type="locator" xlink:label="dei_EntityAddressStateOrProvince" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityAddressStateOrProvince" order="35.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityAddressPostalZipCode" xlink:type="locator" xlink:label="dei_EntityAddressPostalZipCode" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityAddressPostalZipCode" order="36.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_CityAreaCode" xlink:type="locator" xlink:label="dei_CityAreaCode" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_CityAreaCode" order="37.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_LocalPhoneNumber" xlink:type="locator" xlink:label="dei_LocalPhoneNumber" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_LocalPhoneNumber" order="38.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_WrittenCommunications" xlink:type="locator" xlink:label="dei_WrittenCommunications" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_WrittenCommunications" order="39.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_SolicitingMaterial" xlink:type="locator" xlink:label="dei_SolicitingMaterial" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_SolicitingMaterial" order="40.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_PreCommencementTenderOffer" xlink:type="locator" xlink:label="dei_PreCommencementTenderOffer" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_PreCommencementTenderOffer" order="41.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_PreCommencementIssuerTenderOffer" xlink:type="locator" xlink:label="dei_PreCommencementIssuerTenderOffer" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_PreCommencementIssuerTenderOffer" order="42.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_Security12bTitle" xlink:type="locator" xlink:label="dei_Security12bTitle" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_Security12bTitle" order="43.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_TradingSymbol" xlink:type="locator" xlink:label="dei_TradingSymbol" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_TradingSymbol" order="44.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityEmergingGrowthCompany" xlink:type="locator" xlink:label="dei_EntityEmergingGrowthCompany" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityEmergingGrowthCompany" order="45.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityExTransitionPeriod" xlink:type="locator" xlink:label="dei_EntityExTransitionPeriod" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityExTransitionPeriod" order="46.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </link:presentationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>6
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140195930102120">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Document and Entity Information<br></strong></div></th>
<th class="th"><div>Jun. 08, 2022</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_CoverAbstract', window );"><strong>Cover [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NASDAQ<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity Central Index Key</a></td>
<td class="text">0001840229<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentType', window );">Document Type</a></td>
<td class="text">8-K<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentPeriodEndDate', window );">Document Period End Date</a></td>
<td class="text">Jun.  08,  2022<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity Registrant Name</a></td>
<td class="text">MiNK Therapeutics, Inc.<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityIncorporationStateCountryCode', window );">Entity Incorporation State Country Code</a></td>
<td class="text">DE<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityFileNumber', window );">Entity File Number</a></td>
<td class="text">001-40908<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityTaxIdentificationNumber', window );">Entity Tax Identification Number</a></td>
<td class="text">82-2142067<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressAddressLine1', window );">Entity Address, Address Line One</a></td>
<td class="text">149 Fifth Avenue<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressAddressLine2', window );">Entity Address, Address Line Two</a></td>
<td class="text">Suite 500<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressCityOrTown', window );">Entity Address, City or Town</a></td>
<td class="text">New York<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressStateOrProvince', window );">Entity Address, State or Province</a></td>
<td class="text">NY<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressPostalZipCode', window );">Entity Address, Postal Zip Code</a></td>
<td class="text">10010<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_CityAreaCode', window );">City Area Code</a></td>
<td class="text">(212)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_LocalPhoneNumber', window );">Local Phone Number</a></td>
<td class="text">994-8250<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_WrittenCommunications', window );">Written Communications</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_SolicitingMaterial', window );">Soliciting Material</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_PreCommencementTenderOffer', window );">Pre Commencement Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_PreCommencementIssuerTenderOffer', window );">Pre Commencement Issuer Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_Security12bTitle', window );">Security 12b Title</a></td>
<td class="text">Common stock, par value $0.00001<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">INKT<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityEmergingGrowthCompany', window );">Entity Emerging Growth Company</a></td>
<td class="text">true<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityExTransitionPeriod', window );">Entity Ex Transition Period</a></td>
<td class="text">false<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CityAreaCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Area code of city</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CityAreaCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CoverAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Cover page.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CoverAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentPeriodEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentPeriodEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Address Line 1 such as Attn, Building Name, Street Name</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine2">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Address Line 2 such as Street or Suite number</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine2</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressCityOrTown">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Name of the City or Town</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressCityOrTown</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressPostalZipCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Code for the postal or zip code</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressPostalZipCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressStateOrProvince">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Name of the state or province.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressStateOrProvince</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:stateOrProvinceItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityEmergingGrowthCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate if registrant meets the emerging growth company criteria.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityEmergingGrowthCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityExTransitionPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate if an emerging growth company has elected not to use the extended transition period for complying with any new or revised financial accounting standards.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 7A<br> -Section B<br> -Subsection 2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityExTransitionPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFileNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFileNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fileNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityIncorporationStateCountryCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Two-character EDGAR code representing the state or country of incorporation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityIncorporationStateCountryCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarStateCountryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityTaxIdentificationNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityTaxIdentificationNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:employerIdItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LocalPhoneNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Local phone number for entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LocalPhoneNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementIssuerTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 13e<br> -Subsection 4c<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementIssuerTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 14d<br> -Subsection 2b<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_Security12bTitle">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Title of a 12(b) registered security.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_Security12bTitle</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:securityTitleItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SecurityExchangeName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Name of the Exchange on which a security is registered.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection d1-1<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SecurityExchangeName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarExchangeCodeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SolicitingMaterial">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Section 14a<br> -Number 240<br> -Subsection 12<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SolicitingMaterial</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_TradingSymbol">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Trading symbol of an instrument as listed on an exchange.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_TradingSymbol</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:tradingSymbolItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_WrittenCommunications">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br> -Section 425<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_WrittenCommunications</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>7
<FILENAME>d364118d8k_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:dei="http://xbrl.sec.gov/dei/2021"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:xlink="http://www.w3.org/1999/xlink">
    <link:schemaRef xlink:href="inkt-20220608.xsd" xlink:type="simple"/>
    <context id="duration_2022-06-08_to_2022-06-08">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001840229</identifier>
        </entity>
        <period>
            <startDate>2022-06-08</startDate>
            <endDate>2022-06-08</endDate>
        </period>
    </context>
    <dei:SecurityExchangeName
      contextRef="duration_2022-06-08_to_2022-06-08"
      id="Hidden_dei_SecurityExchangeName">NASDAQ</dei:SecurityExchangeName>
    <dei:AmendmentFlag contextRef="duration_2022-06-08_to_2022-06-08">false</dei:AmendmentFlag>
    <dei:EntityCentralIndexKey
      contextRef="duration_2022-06-08_to_2022-06-08"
      id="Hidden_dei_EntityCentralIndexKey">0001840229</dei:EntityCentralIndexKey>
    <dei:DocumentType contextRef="duration_2022-06-08_to_2022-06-08">8-K</dei:DocumentType>
    <dei:DocumentPeriodEndDate contextRef="duration_2022-06-08_to_2022-06-08">2022-06-08</dei:DocumentPeriodEndDate>
    <dei:EntityRegistrantName contextRef="duration_2022-06-08_to_2022-06-08">MiNK Therapeutics, Inc.</dei:EntityRegistrantName>
    <dei:EntityIncorporationStateCountryCode contextRef="duration_2022-06-08_to_2022-06-08">DE</dei:EntityIncorporationStateCountryCode>
    <dei:EntityFileNumber contextRef="duration_2022-06-08_to_2022-06-08">001-40908</dei:EntityFileNumber>
    <dei:EntityTaxIdentificationNumber contextRef="duration_2022-06-08_to_2022-06-08">82-2142067</dei:EntityTaxIdentificationNumber>
    <dei:EntityAddressAddressLine1 contextRef="duration_2022-06-08_to_2022-06-08">149 Fifth Avenue</dei:EntityAddressAddressLine1>
    <dei:EntityAddressAddressLine2 contextRef="duration_2022-06-08_to_2022-06-08">Suite 500</dei:EntityAddressAddressLine2>
    <dei:EntityAddressCityOrTown contextRef="duration_2022-06-08_to_2022-06-08">New York</dei:EntityAddressCityOrTown>
    <dei:EntityAddressStateOrProvince contextRef="duration_2022-06-08_to_2022-06-08">NY</dei:EntityAddressStateOrProvince>
    <dei:EntityAddressPostalZipCode contextRef="duration_2022-06-08_to_2022-06-08">10010</dei:EntityAddressPostalZipCode>
    <dei:CityAreaCode contextRef="duration_2022-06-08_to_2022-06-08">(212)</dei:CityAreaCode>
    <dei:LocalPhoneNumber contextRef="duration_2022-06-08_to_2022-06-08">994-8250</dei:LocalPhoneNumber>
    <dei:WrittenCommunications contextRef="duration_2022-06-08_to_2022-06-08">false</dei:WrittenCommunications>
    <dei:SolicitingMaterial contextRef="duration_2022-06-08_to_2022-06-08">false</dei:SolicitingMaterial>
    <dei:PreCommencementTenderOffer contextRef="duration_2022-06-08_to_2022-06-08">false</dei:PreCommencementTenderOffer>
    <dei:PreCommencementIssuerTenderOffer contextRef="duration_2022-06-08_to_2022-06-08">false</dei:PreCommencementIssuerTenderOffer>
    <dei:Security12bTitle contextRef="duration_2022-06-08_to_2022-06-08">Common stock, par value $0.00001</dei:Security12bTitle>
    <dei:TradingSymbol contextRef="duration_2022-06-08_to_2022-06-08">INKT</dei:TradingSymbol>
    <dei:EntityEmergingGrowthCompany contextRef="duration_2022-06-08_to_2022-06-08">true</dei:EntityEmergingGrowthCompany>
    <dei:EntityExTransitionPeriod contextRef="duration_2022-06-08_to_2022-06-08">false</dei:EntityExTransitionPeriod>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EXCEL
<SEQUENCE>8
<FILENAME>Financial_Report.xlsx
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 Financial_Report.xlsx
M4$L#!!0    ( $*'SE0'04UB@0   +$    0    9&]C4')O<',O87!P+GAM
M;$V./0L",1!$_\IQO;=!P4)B0-!2L+(/>QLOD&1#LD)^OCG!CVX>;QA&WPIG
M*N*I#BV&5(_C(I(/ !47BK9.7:=N')=HI6-Y #OGD<Z,STA)8*O4'J@)I9GF
M3?X.CD:?<@X>K7A.YNJQ<&4GPZ4A!0W_<FW>J=0U[R;UEA_6\#MI7E!+ P04
M    " !"A\Y4;BT5MN\    K @  $0   &1O8U!R;W!S+V-O<F4N>&ULS9+!
M:L,P#(9?9?B>R'&[,DR:RT9/'0Q6V-C-V&IK&L?&UDCZ]G.R-F5L#["CI=^?
M/H%J':3V$5^B#QC)8KH;7-LEJ<.:'8F"!$CZB$ZE,B>ZW-S[Z!3E9SQ 4/JD
M#@B"\Q4X)&44*1B!19B)K*F-ECJB(A\O>*-G?/B,[00S&K!%AQTEJ,H*6#-.
M#.>AK>$&&&&$T:7O IJ9.%7_Q$X=8)?DD.R<ZON^[!=3+N]0P?OS]G5:M[!=
M(M5IS+^2E70.N&;7R6^+QZ?=AC6""U'P55$M=X++^P?)EQ^CZP^_F[#SQN[M
M/S:^"C8U_+J+Y@M02P,$%     @ 0H?.5)E<G",0!@  G"<  !,   !X;"]T
M:&5M92]T:&5M93$N>&UL[5I;<]HX%'[OK]!X9_9M"\8V@;:T$W-I=MNTF83M
M3A^%$5B-;'EDD81_OT<V$,N6#>V23;J;/ 0LZ?O.14?GZ#AY\^XN8NB&B)3R
M>&#9+]O6N[<OWN!7,B0103 9IZ_PP JE3%ZU6FD PSA]R1,2P]R"BPA+>!3+
MUES@6QHO(];JM-O=5H1I;*$81V1@?5XL:$#05%%:;U\@M.4?,_@5RU2-9:,!
M$U=!)KF(M/+Y;,7\VMX^9<_I.ATR@6XP&U@@?\YOI^1.6HCA5,+$P&IG/U9K
MQ]'22(""R7V4!;I)]J/3%0@R#3LZG5C.=GSVQ.V?C,K:=#1M&N#C\7@XMLO2
MBW <!.!1NY["G?1LOZ1!";2C:=!DV/;:KI&FJHU33]/W?=_KFVB<"HU;3]-K
M=]W3CHG&K=!X#;[Q3X?#KHG&J]!TZVDF)_VN:Z3I%FA"1N/K>A(5M>5 TR
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M!Z.:60F]A%9JGZJ'-#ZH'C(*!?&Y'C[E>G@*-Y;&O%"N@GL!_]':-\*K^(+
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MU4#E/]O4#6CV#30<D05>,9FV-J/D3@H\W/[O#;#"Q([A[8N_ 5!+ P04
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M7>EYIK=WDWM)J'7N0;#W\!J-'<V/'[?\ 5!+ P04    " !"A\Y4)!Z;HJT
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M2P$"% ,4    " !"A\Y4!T%-8H$   "Q    $               @ $
M9&]C4')O<',O87!P+GAM;%!+ 0(4 Q0    ( $*'SE1N+16V[P   "L"   1
M              "  :\   !D;V-0<F]P<R]C;W)E+GAM;%!+ 0(4 Q0    (
M $*'SE297)PC$ 8  )PG   3              "  <T!  !X;"]T:&5M92]T
M:&5M93$N>&UL4$L! A0#%     @ 0H?.5%_1A&ME!   <A$  !@
M     ("!#@@  'AL+W=O<FMS:&5E=',O<VAE970Q+GAM;%!+ 0(4 Q0    (
M $*'SE2?H!OPL0(  .(,   -              "  :D,  !X;"]S='EL97,N
M>&UL4$L! A0#%     @ 0H?.5)>*NQS     $P(   L              ( !
MA0\  %]R96QS+RYR96QS4$L! A0#%     @ 0H?.5!PX9>H_ 0  / (   \
M             ( !;A   'AL+W=O<FMB;V]K+GAM;%!+ 0(4 Q0    ( $*'
MSE0D'INBK0   /@!   :              "  =H1  !X;"]?<F5L<R]W;W)K
M8F]O:RYX;6PN<F5L<U!+ 0(4 Q0    ( $*'SE1ED'F2&0$  ,\#   3
M          "  ;\2  !;0V]N=&5N=%]4>7!E<UTN>&UL4$L%!@     )  D
*/@(   D4      $!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>9
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>10
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
..report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

..report table.authRefData a {
	display: block;
	font-weight: bold;
}

..report table.authRefData p {
	margin-top: 0px;
}

..report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

..report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

..report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

..report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
..pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
..report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

..report hr {
	border: 1px solid #acf;
}

/* Top labels */
..report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

..report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

..report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

..report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

..report td.pl div.a {
	width: 200px;
}

..report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
..report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
..report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
..report .re, .report .reu {
	background-color: #def;
}

..report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
..report .ro, .report .rou {
	background-color: white;
}

..report .rou td {
	border-bottom: 1px solid black;
}

..report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
..report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
..report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

..report .nump {
	padding-left: 2em;
}

..report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
..report .text {
	text-align: left;
	white-space: normal;
}

..report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

..report .text .more {
	display: none;
}

..report .text .note {
	font-style: italic;
	font-weight: bold;
}

..report .text .small {
	width: 10em;
}

..report sup {
	font-style: italic;
}

..report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>11
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.22.1</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>1</ContextCount>
  <ElementCount>24</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>false</FootnotesReported>
  <SegmentCount>0</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>0</UnitCount>
  <MyReports>
    <Report instance="d364118d8k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>100000 - Document - Document and Entity Information</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://minktherapeutics.com//20220608/taxonomy/role/DocumentDocumentAndEntityInformation</Role>
      <ShortName>Document and Entity Information</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <InputFiles>
    <File doctype="8-K" original="d364118d8k.htm">d364118d8k.htm</File>
    <File>d364118dex101.htm</File>
    <File>inkt-20220608.xsd</File>
    <File>inkt-20220608_lab.xml</File>
    <File>inkt-20220608_pre.xml</File>
  </InputFiles>
  <SupplementalFiles/>
  <BaseTaxonomies>
    <BaseTaxonomy items="24">http://xbrl.sec.gov/dei/2021</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>true</HasPresentationLinkbase>
  <HasCalculationLinkbase>false</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>14
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
{
 "instance": {
  "d364118d8k.htm": {
   "axisCustom": 0,
   "axisStandard": 0,
   "contextCount": 1,
   "dts": {
    "inline": {
     "local": [
      "d364118d8k.htm"
     ]
    },
    "labelLink": {
     "local": [
      "inkt-20220608_lab.xml"
     ]
    },
    "presentationLink": {
     "local": [
      "inkt-20220608_pre.xml"
     ]
    },
    "schema": {
     "local": [
      "inkt-20220608.xsd"
     ],
     "remote": [
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "http://www.xbrl.org/dtr/type/nonNumeric-2009-12-16.xsd",
      "http://www.xbrl.org/dtr/type/numeric-2009-12-16.xsd",
      "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd",
      "https://xbrl.sec.gov/dei/2021/dei-2021.xsd",
      "https://xbrl.sec.gov/naics/2021/naics-2021.xsd"
     ]
    }
   },
   "elementCount": 25,
   "entityCount": 1,
   "hidden": {
    "http://xbrl.sec.gov/dei/2021": 3,
    "total": 3
   },
   "keyCustom": 0,
   "keyStandard": 24,
   "memberCustom": 0,
   "memberStandard": 0,
   "nsprefix": "inkt",
   "nsuri": "http://minktherapeutics.com/20220608",
   "report": {
    "R1": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "p",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "d364118d8k.htm",
      "contextRef": "duration_2022-06-08_to_2022-06-08",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:DocumentType",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "document",
     "isDefault": "true",
     "longName": "100000 - Document - Document and Entity Information",
     "role": "http://minktherapeutics.com//20220608/taxonomy/role/DocumentDocumentAndEntityInformation",
     "shortName": "Document and Entity Information",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "p",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "d364118d8k.htm",
      "contextRef": "duration_2022-06-08_to_2022-06-08",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:DocumentType",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    }
   },
   "segmentCount": 0,
   "tag": {
    "dei_AmendmentFlag": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.",
        "label": "Amendment Flag",
        "terseLabel": "Amendment Flag"
       }
      }
     },
     "localname": "AmendmentFlag",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://minktherapeutics.com//20220608/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_CityAreaCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Area code of city",
        "label": "City Area Code",
        "terseLabel": "City Area Code"
       }
      }
     },
     "localname": "CityAreaCode",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://minktherapeutics.com//20220608/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_CoverAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cover page.",
        "label": "Cover [Abstract]",
        "terseLabel": "Cover [Abstract]"
       }
      }
     },
     "localname": "CoverAbstract",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "xbrltype": "stringItemType"
    },
    "dei_DocumentPeriodEndDate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD.",
        "label": "Document Period End Date",
        "terseLabel": "Document Period End Date"
       }
      }
     },
     "localname": "DocumentPeriodEndDate",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://minktherapeutics.com//20220608/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "dateItemType"
    },
    "dei_DocumentType": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.",
        "label": "Document Type",
        "terseLabel": "Document Type"
       }
      }
     },
     "localname": "DocumentType",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://minktherapeutics.com//20220608/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "submissionTypeItemType"
    },
    "dei_EntityAddressAddressLine1": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Address Line 1 such as Attn, Building Name, Street Name",
        "label": "Entity Address, Address Line One",
        "terseLabel": "Entity Address, Address Line One"
       }
      }
     },
     "localname": "EntityAddressAddressLine1",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://minktherapeutics.com//20220608/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressAddressLine2": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Address Line 2 such as Street or Suite number",
        "label": "Entity Address, Address Line Two",
        "terseLabel": "Entity Address, Address Line Two"
       }
      }
     },
     "localname": "EntityAddressAddressLine2",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://minktherapeutics.com//20220608/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressCityOrTown": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the City or Town",
        "label": "Entity Address, City or Town",
        "terseLabel": "Entity Address, City or Town"
       }
      }
     },
     "localname": "EntityAddressCityOrTown",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://minktherapeutics.com//20220608/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressPostalZipCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Code for the postal or zip code",
        "label": "Entity Address, Postal Zip Code",
        "terseLabel": "Entity Address, Postal Zip Code"
       }
      }
     },
     "localname": "EntityAddressPostalZipCode",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://minktherapeutics.com//20220608/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressStateOrProvince": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the state or province.",
        "label": "Entity Address, State or Province",
        "terseLabel": "Entity Address, State or Province"
       }
      }
     },
     "localname": "EntityAddressStateOrProvince",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://minktherapeutics.com//20220608/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "stateOrProvinceItemType"
    },
    "dei_EntityCentralIndexKey": {
     "auth_ref": [
      "r5"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.",
        "label": "Entity Central Index Key",
        "terseLabel": "Entity Central Index Key"
       }
      }
     },
     "localname": "EntityCentralIndexKey",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://minktherapeutics.com//20220608/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "centralIndexKeyItemType"
    },
    "dei_EntityEmergingGrowthCompany": {
     "auth_ref": [
      "r5"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate if registrant meets the emerging growth company criteria.",
        "label": "Entity Emerging Growth Company",
        "terseLabel": "Entity Emerging Growth Company"
       }
      }
     },
     "localname": "EntityEmergingGrowthCompany",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://minktherapeutics.com//20220608/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityExTransitionPeriod": {
     "auth_ref": [
      "r7"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate if an emerging growth company has elected not to use the extended transition period for complying with any new or revised financial accounting standards.",
        "label": "Entity Ex Transition Period",
        "terseLabel": "Entity Ex Transition Period"
       }
      }
     },
     "localname": "EntityExTransitionPeriod",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://minktherapeutics.com//20220608/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityFileNumber": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.",
        "label": "Entity File Number",
        "terseLabel": "Entity File Number"
       }
      }
     },
     "localname": "EntityFileNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://minktherapeutics.com//20220608/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "fileNumberItemType"
    },
    "dei_EntityIncorporationStateCountryCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Two-character EDGAR code representing the state or country of incorporation.",
        "label": "Entity Incorporation State Country Code",
        "terseLabel": "Entity Incorporation State Country Code"
       }
      }
     },
     "localname": "EntityIncorporationStateCountryCode",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://minktherapeutics.com//20220608/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "edgarStateCountryItemType"
    },
    "dei_EntityRegistrantName": {
     "auth_ref": [
      "r5"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.",
        "label": "Entity Registrant Name",
        "terseLabel": "Entity Registrant Name"
       }
      }
     },
     "localname": "EntityRegistrantName",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://minktherapeutics.com//20220608/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityTaxIdentificationNumber": {
     "auth_ref": [
      "r5"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.",
        "label": "Entity Tax Identification Number",
        "terseLabel": "Entity Tax Identification Number"
       }
      }
     },
     "localname": "EntityTaxIdentificationNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://minktherapeutics.com//20220608/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "employerIdItemType"
    },
    "dei_LocalPhoneNumber": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Local phone number for entity.",
        "label": "Local Phone Number",
        "terseLabel": "Local Phone Number"
       }
      }
     },
     "localname": "LocalPhoneNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://minktherapeutics.com//20220608/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_PreCommencementIssuerTenderOffer": {
     "auth_ref": [
      "r2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.",
        "label": "Pre Commencement Issuer Tender Offer",
        "terseLabel": "Pre Commencement Issuer Tender Offer"
       }
      }
     },
     "localname": "PreCommencementIssuerTenderOffer",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://minktherapeutics.com//20220608/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_PreCommencementTenderOffer": {
     "auth_ref": [
      "r3"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.",
        "label": "Pre Commencement Tender Offer",
        "terseLabel": "Pre Commencement Tender Offer"
       }
      }
     },
     "localname": "PreCommencementTenderOffer",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://minktherapeutics.com//20220608/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_Security12bTitle": {
     "auth_ref": [
      "r0"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Title of a 12(b) registered security.",
        "label": "Security 12b Title",
        "terseLabel": "Security 12b Title"
       }
      }
     },
     "localname": "Security12bTitle",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://minktherapeutics.com//20220608/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "securityTitleItemType"
    },
    "dei_SecurityExchangeName": {
     "auth_ref": [
      "r1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the Exchange on which a security is registered.",
        "label": "Security Exchange Name",
        "terseLabel": "Security Exchange Name"
       }
      }
     },
     "localname": "SecurityExchangeName",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://minktherapeutics.com//20220608/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "edgarExchangeCodeItemType"
    },
    "dei_SolicitingMaterial": {
     "auth_ref": [
      "r4"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.",
        "label": "Soliciting Material",
        "terseLabel": "Soliciting Material"
       }
      }
     },
     "localname": "SolicitingMaterial",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://minktherapeutics.com//20220608/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_TradingSymbol": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Trading symbol of an instrument as listed on an exchange.",
        "label": "Trading Symbol",
        "terseLabel": "Trading Symbol"
       }
      }
     },
     "localname": "TradingSymbol",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://minktherapeutics.com//20220608/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "tradingSymbolItemType"
    },
    "dei_WrittenCommunications": {
     "auth_ref": [
      "r6"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.",
        "label": "Written Communications",
        "terseLabel": "Written Communications"
       }
      }
     },
     "localname": "WrittenCommunications",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://minktherapeutics.com//20220608/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    }
   },
   "unitCount": 0
  }
 },
 "std_ref": {
  "r0": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b"
  },
  "r1": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "d1-1"
  },
  "r2": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "13e",
   "Subsection": "4c"
  },
  "r3": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "14d",
   "Subsection": "2b"
  },
  "r4": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "14a",
   "Subsection": "12"
  },
  "r5": {
   "Name": "Regulation 12B",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b-2"
  },
  "r6": {
   "Name": "Securities Act",
   "Number": "230",
   "Publisher": "SEC",
   "Section": "425"
  },
  "r7": {
   "Name": "Securities Act",
   "Number": "7A",
   "Publisher": "SEC",
   "Section": "B",
   "Subsection": "2"
  }
 },
 "version": "2.1"
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>15
<FILENAME>0001193125-22-173902-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0001193125-22-173902-xbrl.zip
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M!N&?A':9%@GI':MV):-?,1#+/=:B]P(D9&G&V7KJBOV2G#21@CBUM""1B;&
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MM1WX5"9N>-/P5E)4WHU'G-5H *_*ZM6V;]_H?%TDR9!:P%FRL&U\]F#Y 5L
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M]#F7#B<>S>XK;Q,_V7ZMJ@Y+8!;B<17Z=-3B@;XHJ^N#\[MV%))(['%7DCI
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M'0(?&)"E1,'PLLHG?S:.X@B'O4FF&MC,/+\%?;.(^>QG+74B89Q'-1!& _"
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M9S-.C%&I9+22\..@A9=*;>PC=9,G4U._.LWK,0J S'L1G15@RV4@:TLV>;E
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M&+,.<S,D[HI\8&OQS3>Q\GE2=#B8V;'N(@*59)IOS<3#97*<H;$^2I]?Q-R
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M^_,)3H8 :4VFP4\N-]0;]CKC]+<,EF_9M^7=HA_(-4FYLUYC-&*P?6^U>;6
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M4>V4-+*%LS+2'TXG-(D;KXK<Y76\(O+  #<?QU@)N:^%=5%3+"14ZI#*HZV
MQ.W7N/K1HFDW4"<BT-^:<+==3+GU)?BCI(X0-;?.#0==X#0((9&9*T,F[4QE
M"XV6D;3M%N.QR,6"B)DJ]IO@ZV2N7L.7 6NX_K%"HM,'(_6V^-%0]T<C-;*X
MST:*0I!5@KP4TJ.1%FT8GHTT]H(R ALU<$Q2?1,F6TC4D']#?K?P5QOB]7$(
MV%=H(C._@5V9?/47%O M&3#1;N.BO.-:;>EO%\IWT>P[=M2>_P%02P,$%
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MN?PH0$6*)?K:(RSQ;/G]#]LBU\%!7@:ZP!Q@SJ^8?^8XKB[Y%U!+ 0(4 Q0
M   ( $*'SE3].!FBQ!<  )RC   .              "  0    !D,S8T,3$X
M9#AK+FAT;5!+ 0(4 Q0    ( $*'SE19>JC0JRT  /'!   1
M  "  ? 7  !D,S8T,3$X9&5X,3 Q+FAT;5!+ 0(4 Q0    ( $*'SE33>EP7
M1P,  & +   1              "  <I%  !I;FMT+3(P,C(P-C X+GAS9%!+
M 0(4 Q0    ( $*'SE3<8DY>K@8  *9)   5              "  4!)  !I
M;FMT+3(P,C(P-C X7VQA8BYX;6Q02P$"% ,4    " !"A\Y4CW$0A.4$   )
M+@  %0              @ $A4   :6YK="TR,#(R,#8P.%]P<F4N>&UL4$L%
3!@     %  4 0 $  #E5      $!

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
